The Autotaxin-LPA Axis Emerges as a Novel Regulator of Smooth Muscle Cell Phenotypic Modulation during Intimal Hyperplasia

• Published in: International journal of molecular sciences Vol. 24; no. 3; p. 2913
• Main Authors: Subedi, Utsab, Manikandan, Shrivats, Bhattarai, Susmita, Sharma, Papori, Sharma, Sudha, Sun, Hong, Miriyala, Sumitra, Panchatcharam, Manikandan
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 02-02-2023; MDPI
• Subjects: Angioplasty; Animals; Antigens; Atherosclerosis; autotaxin; Blood platelets; Cardiovascular disease; Carotid arteries; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Enzymes; Hyperplasia; Hyperplasia - pathology; Injuries; Lysophosphatidic acid; Lysophospholipase; Mice; Muscle contraction; Muscles; Myocytes, Smooth Muscle - pathology; Neointima - pathology; neointimal hyperplasia; Phenotype; Phenotypes; Protein expression; Real time; Restenosis; Smooth muscle; smooth muscle cells; Stents; Veins & arteries; Wound healing; smooth muscle cells; restenosis; lysophosphatidic acid; autotaxin; neointimal hyperplasia
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms24032913

Neointimal hyperplasia is characterized by a loss of the contractile phenotype of vascular smooth muscle cells (VSMCs). Our group has recently shown that VSMC proliferation and migration are mediated by lysophosphatidic acid (LPA) during restenosis, but the role of autotaxin (ATX; lysophospholipase D), which produces LPA, remains unclear. Endothelial denudation of the mouse carotid artery was performed to induce neointimal hyperplasia, and the extent of damage caused by the ATX-LPA axis was assessed in VSMCs. We observed the upregulation of ATX activity (
< 0.0002) in the injured carotid artery using an AR2 probe fluorescence assay. Further, the tissue carotid LPA levels were elevated 2.7-fold in carotid vessels, augmenting neointimal hyperplasia. We used an electrical cell-substrate impedance sensor (ECIS) to measure VSMC proliferation and migration. Treatment with an ATX inhibitor (PF8380) or LPA receptor inhibitor (Ki16425) attenuated VSMC proliferation (extracellular signal-regulated kinases) activity and migration in response to recombinant ATX. Indeed, PF8380 treatment rescued the aggravated post-wire injury neointima formation of carotid arteries. The upregulation of ATX following vessel injury leads to LPA production in VSMCs, favoring restenosis. Our observations suggest that inhibition of the ATX-LPA axis could be therapeutically targeted in restenosis to minimize VSMC phenotypic modulation and inflammation after vascular injury.